Literature DB >> 16456665

Coexistence of PSP and MSA: a case report and review of the literature.

Hirotake Uchikado1, Anthony DelleDonne, Ryan Uitti, Dennis W Dickson.   

Abstract

Progressive supranuclear palsy (PSP) is a neurodegenerative tauopathy characterized by Parkinsonism, vertical gaze palsy, and early falls. The neuropathology is characterized by neurofibrillary tangles, tufted astrocytes, and coiled bodies, but some brains show other pathologic processes. To investigate the frequency of alpha-synuclein pathology in PSP with immunohistochemistry and to report the clinical and pathological features of a case of PSP with concomitant Multiple system atrophy (MSA) (PSP/MSA), 290 cases of PSP were screened for alpha-synuclein pathology with immunohistochemistry. Double-labeling immunohistochemistry was performed on a case of PSP/MSA. Among the PSP cases screened for alpha-synuclein pathology, a single case of PSP/MSA was detected. The patient was an 86-year-old woman with clinical features consistent with PSP. She had no documented dysautonomia or cerebellar signs, and imaging studies were not diagnostic of MSA. Pathological examination showed tau-immunoreactive neuronal and glial lesions consistent with PSP as well as alpha-synuclein immunoreactive glial cytoplasmic inclusions diagnostic of MSA. Double-immunolabeling studies showed no co-localization of alpha-synuclein and tau in most neuronal and glial lesions. Based upon the findings in this case, the neuropathologic changes of PSP and MSA are distinct and independent processes, but they can occasionally coexist.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16456665     DOI: 10.1007/s00401-005-0022-z

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  14 in total

Review 1.  Diagnosis and differential diagnosis of MSA: boundary issues.

Authors:  Han-Joon Kim; Beom S Jeon; Kurt A Jellinger
Journal:  J Neurol       Date:  2015-02-07       Impact factor: 4.849

2.  Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy.

Authors:  Hirotake Uchikado; Wen-Lang Lin; Michael W DeLucia; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2006-07       Impact factor: 3.685

3.  Multiple system atrophy and repeat expansions in C9orf72--reply.

Authors:  Jill S Goldman; Sheng-Han Kuo
Journal:  JAMA Neurol       Date:  2014-09       Impact factor: 18.302

Review 4.  The Role of Tau Imaging in Parkinsonian Disorders.

Authors:  Jochen Hammes; Alexander Drzezga; Thilo van Eimeren
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-06       Impact factor: 5.081

5.  Cortical Alzheimer type pathology does not influence tau pathology in progressive supranuclear palsy.

Authors:  Kenichi Oshima; Dennis W Dickson
Journal:  Int J Clin Exp Pathol       Date:  2008-12-20

6.  Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy?

Authors:  Hiroshige Fujishiro; Tae-Beom Ahn; Roberta Frigerio; Anthony DelleDonne; Keith A Josephs; Joseph E Parisi; J Eric Ahlskog; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2008-06-14       Impact factor: 17.088

7.  Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis?

Authors:  B Mollenhauer; M Bibl; H Esselmann; P Steinacker; C Trenkwalder; J Wiltfang; M Otto
Journal:  J Neural Transm (Vienna)       Date:  2007-02-22       Impact factor: 3.850

8.  When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients.

Authors:  Shunsuke Koga; Naoya Aoki; Ryan J Uitti; Jay A van Gerpen; William P Cheshire; Keith A Josephs; Zbigniew K Wszolek; J William Langston; Dennis W Dickson
Journal:  Neurology       Date:  2015-07-02       Impact factor: 9.910

9.  Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia: Case report.

Authors:  Katerina Mensikova; Lucie Tuckova; Jiri Ehrmann; Petr Kanovsky
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 10.  Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms.

Authors:  Chul Hyoung Lyoo; Hanna Cho; Jae Yong Choi; Young Hoon Ryu; Myung Sik Lee
Journal:  J Mov Disord       Date:  2018-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.